Clinical Trial Update: Drug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on drug resistance inhibition for women with recurrent or metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED